Result of sentinel lymph node biopsy using radioisotope in clinically lymph node negative breast cancer

被引:6
|
作者
Kim, Hee Jeong [1 ]
Chang, Mi Ae [1 ]
Hong, Soo Jeong [1 ]
Lee, Jung Sun [1 ]
Jung, Min Sung [1 ]
Kim, Mee Jung [2 ]
Gong, Gyung Yub [2 ]
Kim, Euy Nyong [3 ]
Kwak, Beom Seok [4 ]
Ahn, Sei Hyun [1 ]
Son, Byung Ho [1 ]
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Nucl Med, Seoul, South Korea
[4] Dong Guk Univ Int Hosp, Dept Surg, Seoul, South Korea
关键词
sentinel lymph node; early breast cancer; false negative rate;
D O I
10.4048/jbc.2007.10.2.141
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Sentinel lymph node biopsy (SLNB) has been developed to accurately assess the axillary lymph node status accurately without having to remove most of the axillary contents in node negative early breast cancer patients. The aims of this study were to evaluate the accuracy, the false negative rate and the advantage of additional axillary sampling for SLNB with using radioisotope. Methods: Between December 2003 and June 2005, we carried out SLNB for 574 breast cancer patients who were diagnosed and had operation at Asan Medical Center. For detection of the sentinel lymph mode (SLN), radioisotope was injected into the periareolar area on the operating day, breast scintigraphy was performed and finally the biopsy was done using a gamma-detection probe in the operating room. If the SLN turned out to be positive for metastatic malignancy according to the frozen section histology, then additional axillary lymph nodes (LN) dissection was performed. But, if it was free of metastasis, then only axillary node sampling (n <= 5) or no further treatment was done. Results: The mean number of resected SLNs was 2.67 +/- 0.98 (1-7) and the mean number of total LN was 8.5 +/- 5.0 (1-38). The SLN was detected 82.8% of the time on lymphoscintigraphy and 98.4% of the time with the gamma probe. Axillary metastasis was founded in 118 cases (20.9%). The accuracy was 98.2%, and the false negative rate was 7.89%. For the SLN positive cases, there were 73/78 cases (93.6%) of list SLN metastasis, there were 75/78 cases (93.6%) of 1st and 2nd SLN metastasis, and 75178 (93.6%) of 1 st to 3rd SLN metastasis. The false negative rate of the alternative frozen section was 40% and that of the full frozen section was 24.1%. The difference was statistically significant. Conclusion: SLNB using Tc-99m-antimony trisulfide colloid (0.5 mCi) showed a high detection rate and a low false negative rate. The false negative rate was decreased by using full section H&E staining and at least 3 SLNs showed the exact LN status. Even if the SLN was free of metastasis, additional sampling may decrease the false negative rate.
引用
收藏
页码:141 / 146
页数:6
相关论文
共 50 条
  • [1] Evaluation of Sentinel Lymph Node Biopsy in Clinically Node-Negative Breast Cancer
    Iida, Shinya
    Haga, Shunsuke
    Yamashita, Koji
    Yanagihara, Keiko
    Kurita, Tomoko
    Murakami, Ryusuke
    Kumita, Shin-ichiro
    Tsuchiya, Shin-ichi
    Furukawa, Kiyonori
    Uchida, Eiji
    [J]. JOURNAL OF NIPPON MEDICAL SCHOOL, 2011, 78 (02) : 96 - 100
  • [2] Clinically node-negative breast cancer, internal mammary lymph nodes, and sentinel lymph node biopsy
    Ramsay, Stuart C.
    Cassidy, Nathan
    Meade, Sally
    [J]. CLINICAL NUCLEAR MEDICINE, 2008, 33 (06) : 391 - 393
  • [3] SENTINEL LYMPH NODE BIOPSY IN NODE NEGATIVE BREAST CANCER PATIENTS
    Krishnamurthy, S. V.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 : 24 - 24
  • [4] Factors Predicting Positive Sentinel Lymph Node Biopsy in Clinically Node-Negative Breast Cancer
    Alsumai, Thuraya S.
    Alhazzaa, Norah
    Alshamrani, Abdullah
    Assiri, Sarah
    Alhefdhi, Amal
    [J]. BREAST CANCER-TARGETS AND THERAPY, 2022, 14 : 323 - 334
  • [5] Probability of axillary lymph node metastasis when sentinel lymph node biopsy is negative in women with clinically node negative breast cancer: A Bayesian approach
    Okamoto T.
    Yamazaki K.
    Kanbe M.
    Kodama H.
    Omi Y.
    Kawamata A.
    Suzuki R.
    Igari Y.
    Tanaka R.
    Lihara M.
    Ito Y.
    Sawada T.
    Nishikawa T.
    Maki M.
    Kusakabe K.
    Mitsuhashi N.
    Obara T.
    [J]. Breast Cancer, 2005, 12 (3) : 203 - 210
  • [6] Monocentric experience with the sentinel lymph node biopsy prior to neoadjuvant chemotherapy in clinically lymph node negative early breast cancer
    Delameilleure, M.
    Smeets, A.
    Nevelsteen, I.
    Han, S.
    Van Nieuwenhuysen, E.
    Berteloot, P.
    Hoste, G.
    Salihi, R.
    Van Ongeval, C.
    Keupers, M.
    Prevos, R.
    Wildiers, H.
    Punie, K.
    Van Limbergen, E.
    Weltens, C.
    Janssen, H.
    Floris, G.
    Vergote, I.
    Neven, P.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [7] Sentinel node biopsy in breast cancer patients with clinically negative lymph-nodes
    Motomura K.
    Inaji H.
    Komoike Y.
    Kasugai T.
    Nagumo S.
    Noguchi S.
    Koyama H.
    [J]. Breast Cancer, 1999, 6 (3) : 259 - 262
  • [8] Sentinel lymph node biopsy in breast cancer [Sentinel lymph node beim mammakarzinom]
    Rody A.
    Solbach C.
    Kaufmann M.
    [J]. Der Chirurg, 2004, 75 (8): : 767 - 773
  • [9] Role of Combined Sentinel Lymph Node Biopsy and Axillary Node Sampling in Clinically Node-Negative Breast Cancer
    Edwards, K. J.
    Dordea, M. A.
    French, R.
    Kurup, V.
    [J]. INDIAN JOURNAL OF SURGERY, 2015, 77 (06) : 495 - 501
  • [10] Role of Combined Sentinel Lymph Node Biopsy and Axillary Node Sampling in Clinically Node-Negative Breast Cancer
    K. J. Edwards
    M. A. Dordea
    R. French
    V. Kurup
    [J]. Indian Journal of Surgery, 2015, 77 : 495 - 501